A. Endean

发表

Comment on: Possible miliary tuberculosis during adalimumab therapy with negative γ-IFN release assays: reply

S. Young-Min, A. Endean, S. Barry, 2009 .

Possible miliary tuberculosis during adalimumab therapy with negative gamma-IFN release assays.

S. Young-Min, A. Endean, S. Barry, 2008, Rheumatology.

Review Gusperimus: immunological mechanism and clinical applications RHEUMATOLOGY

D. D'cruz, S. Sangle, A. Endean, 2014 .

Hook sign and arthritis in refractory anaemia with ringed sideroblasts ( myelodysplastic syndrome )

S. Young-Min, A. Endean, S. Barry, 2009 .

Clinical Utility of Random Anti–Tumor Necrosis Factor Drug–Level Testing and Measurement of Antidrug Antibodies on the Long‐Term Treatment Response in Rheumatoid Arthritis

W. Dixon, A. Barton, I. Bruce, 2015, Arthritis & rheumatology.

Potential of Magnetic Resonance Imaging Findings to Refine Case Definition for Mechanical Low Back Pain in Epidemiological Studies: A Systematic Review

K. Palmer, D. Coggon, A. Endean, 2011, Spine.

Potential of Magnetic Resonance Imaging Findings to Refi ne Case Defi nition for Mechanical Low Back Pain in Epidemiological Studies

K. Palmer, D. Coggon, A. Endean, 2011 .

Macrophagic myofasciitis: a report of second case from UK

D. Hilton, A. Shivane, A. Endean, 2012, Neuropathology and applied neurobiology.

Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritis

S. Tuck, B. Harrison, B. Griffiths, 2022, Rheumatology.

Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort

W. Dixon, I. Bruce, Paul Wordsworth, 2013, The Pharmacogenomics Journal.

Myocardial infarction in a young man with antiphospholipid syndrome and cocaine use

E. Williams, C. J. Edwards, A. Endean, 2007, Lupus.